Drug
Azvudine
Azvudine: highest development phase Phase 2/3, developed by Shanghai Fosun Pharmaceutical. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Shanghai Fosun Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Azvudine NCT05633433 | Phase 2/3 | SARS-CoV-2 Infection |
| Azvudine NCT05682599 | Phase 2 | COVID-19 |
Latest
No recent events.
Follow Azvudine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.